Trade AstraZeneca PLC - GBP - AZNl CFD
Add to favourite- Summary
- Historical Data
| Spread | 2.14 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023263% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001346% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | GBP | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 102.59 |
| Open | 100.59 |
| 1-Year Change | -7.52% |
| Day's Range | 100.59 - 101.85 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 17, 2025 | 101.73 | 0.32 | 0.32% | 101.41 | 101.91 | 100.13 |
| Apr 16, 2025 | 102.59 | 1.04 | 1.02% | 101.55 | 103.11 | 101.05 |
| Apr 15, 2025 | 102.51 | 0.02 | 0.02% | 102.49 | 103.25 | 100.59 |
| Apr 14, 2025 | 102.59 | 2.94 | 2.95% | 99.65 | 103.19 | 99.65 |
| Apr 11, 2025 | 98.01 | -2.08 | -2.08% | 100.09 | 100.55 | 98.01 |
| Apr 10, 2025 | 100.01 | -2.44 | -2.38% | 102.45 | 103.35 | 99.40 |
| Apr 9, 2025 | 96.31 | -3.15 | -3.17% | 99.46 | 99.83 | 95.59 |
| Apr 8, 2025 | 103.23 | 0.50 | 0.49% | 102.73 | 104.59 | 99.68 |
| Apr 7, 2025 | 99.80 | -3.71 | -3.58% | 103.51 | 104.45 | 99.12 |
| Apr 4, 2025 | 105.97 | -5.53 | -4.96% | 111.50 | 113.26 | 105.97 |
| Apr 3, 2025 | 111.42 | 0.52 | 0.47% | 110.90 | 115.38 | 110.14 |
| Apr 2, 2025 | 111.90 | -0.50 | -0.44% | 112.40 | 112.88 | 110.42 |
| Apr 1, 2025 | 113.40 | 1.34 | 1.20% | 112.06 | 114.72 | 112.06 |
| Mar 31, 2025 | 111.08 | -2.00 | -1.77% | 113.08 | 113.48 | 111.08 |
| Mar 28, 2025 | 113.68 | 1.60 | 1.43% | 112.08 | 114.30 | 110.90 |
| Mar 27, 2025 | 111.80 | 0.20 | 0.18% | 111.60 | 112.30 | 110.96 |
| Mar 26, 2025 | 112.24 | -0.72 | -0.64% | 112.96 | 113.30 | 110.90 |
| Mar 25, 2025 | 112.22 | -0.02 | -0.02% | 112.24 | 115.62 | 111.20 |
| Mar 24, 2025 | 114.52 | -0.92 | -0.80% | 115.44 | 116.14 | 113.20 |
| Mar 21, 2025 | 115.80 | -2.14 | -1.81% | 117.94 | 118.00 | 115.80 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
AstraZeneca - GBP Company profile
About AstraZeneca plc
AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, AstraZeneca plc revenues increased 41% to $37.42B. Net income decreased 96% to $112M. Revenues reflect Farxiga segment increase of 53% to $3B, Calquenc segment increase from $522M to $1.24B, Tagrisso segment increase of 16% to $5.02B, United States segment increase of 35% to $12.05B, United Kingdom segment increase of 86% to $3.25B, Sweden segment increase from $1.03B to $2.32B.
| Industry: | Pharmaceuticals (NEC) |
1 Francis Crick Avenue
CAMBRIDGE
CAMBRIDGESHIRE CB2 0AA
GB
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com